The Bull Case for Viking Therapeutics Just Got Even Stronger. Here's Why You Should Buy It.The Motley Fool • 07/29/24
Why Viking's Weight-Loss Drug News Is Weighing on Eli Lilly, Novo Nordisk StocksInvestopedia • 07/25/24
Viking Therapeutics: Better-Than-Expected Trial Timelines While Pipeline ExpandsSeeking Alpha • 07/25/24
Viking Therapeutics Unveils Monthly Weight-Loss Shot, And Rocks Eli Lilly, Novo NordiskInvestors Business Daily • 07/25/24
Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trialCNBC • 07/25/24
Viking Therapeutics (VKTX) Stock Pops on Plans to Start Late-Stage Weight Loss Drug TrialsInvestorPlace • 07/25/24
Viking Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate UpdatePRNewsWire • 07/24/24
Missed Out on Eli Lilly? These 2 Healthcare Stocks Have Big Catalysts on the Horizon.The Motley Fool • 07/22/24
Viking Therapeutics: Great Clinical Results Do Not Guarantee Commercialization SuccessSeeking Alpha • 07/20/24
Viking Therapeutics to Report Financial Results for Second Quarter 2024 on July 24, 2024PRNewsWire • 07/17/24